Genetic Modifiers of Sickle Cell Disease.

Genetic Modifiers of Sickle Cell Disease.
复制标题

DOI:
10.1016/j.hoc.2022.06.006
复制
发表时间:
2022-12
期刊:
Hematology/oncology clinics of North America
影响因子:
--
通讯作者:
Thomas Pincez;A. Ashley-Koch;G. Lettre;M. Telen
Thomas Pincez;A. Ashley-Koch;G. Lettre;M. Telen
中科院分区:
其他
文献类型:
--
作者:
Thomas Pincez;A. Ashley-Koch;G. Lettre;M. Telen

文献摘要

相似文献

使用最新的分子技术进步和广泛的统计方法研究遗传变异及其与疾病结局的关系,有可能帮助克服SCD是一种罕见疾病,在临床过程中也是可变的这一事实所带来的几个挑战。
Studies of genetic variants and their associations with disease outcomes using recent molecular technology advances and the broad variety of statistical methodologies available have the potential to help overcome several challenges that arise from the fact that SCD is a rare disease that is also variable in its clinical course.